127 results
Page 2 of 7
8-K
EX-10.2
pmlftuagr vz87bfq
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
utd2 6xzqj
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
fyxnywna2hots3i2iy
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
EX-10.1
485jq
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.2
xxdigflu
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
eafbqdfz hmn09uew9i2
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.2
dr58z2
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.1
jma8 s6a7gt2
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.1
mvxkq8w0ue7oi3f8
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
3lk2ymjg
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
EX-10.2
2o3p0lcls22pw w14yx
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-10.1
wvlpq
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am